Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Transformable Supramolecular Bispecific Cell Engager for Augmenting Natural Killer and T Cell‐Based Cancer Immunotherapy
Yumiao Chen, Wei Li, Zhongqiu Wang, et al.
Advanced Materials (2023) Vol. 36, Iss. 3
Closed Access | Times Cited: 20

Showing 20 citing articles:

Transformable Supramolecular Self‐Assembled Peptides for Cascade Self‐Enhanced Ferroptosis Primed Cancer Immunotherapy
He Wang, Di Jiao, Dexiang Feng, et al.
Advanced Materials (2024) Vol. 36, Iss. 21
Closed Access | Times Cited: 26
Recent developments in immunotherapy for gastrointestinal tract cancers
Xiaoyi Chong, Yelizhati Madeti, Jieyuan Cai, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 21
Cell Membrane as A Promising Therapeutic Target: From Materials Design to Biomedical Applications
Xiaofeng Wu, Jingjing Hu, Juyoung Yoon
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 18
Closed Access | Times Cited: 19
Peptides as Versatile Regulators in Cancer Immunotherapy: Recent Advances, Challenges, and Future Prospects
Yu Lei, Jiacheng Liu, Yaowei Bai, et al.
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 46-46
Open Access | Times Cited: 1
Cell Membrane as A Promising Therapeutic Target: From Materials Design to Biomedical Applications
Xiaofeng Wu, Jingjing Hu, Juyoung Yoon
Angewandte Chemie (2024) Vol. 136, Iss. 18
Closed Access | Times Cited: 5
Blood–Brain Barrier Penetrating Nanovehicles for Interfering with Mitochondrial Electron Flow in Glioblastoma
Yulin Zhang, Kaiyan Xi, Yuying Zhang, et al.
ACS Nano (2024) Vol. 18, Iss. 13, pp. 9511-9524
Closed Access | Times Cited: 4
Whole‐Component Antigen Nanovaccines Combined With aTIGIT for Enhanced Innate and Adaptive Anti‐tumor Immunity
Weitao Wang, Haitao Wu, Xuan Zhang, et al.
Small (2025)
Closed Access
Combined immune-peptide nanofiber with HSP70/AKT/mTOR axis blockade enhances near-infrared photoimmunotherapy, inhibiting tumor growth and recurrence
Yang Du, Xinyu Zhang, Zhenqi Jiang, et al.
Research Square (Research Square) (2025)
Closed Access
Biomimetic Nanomaterials Based on Peptide In Situ Self‐Assembly for Immunotherapy Applications
Zhuan Wen, Zhang‐Zhi Song, M. S. Cai, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2025) Vol. 17, Iss. 1
Closed Access
In situ peptide assembly for cell membrane rewiring in tumor therapy
Yu Ma, Qiaochu Jiang, Xiaoyang Liu, et al.
Journal of Controlled Release (2025), pp. 113637-113637
Closed Access
Provoking Lysosome Disruption via In Situ Engineered Double-Network Assemblies for Targeted Cancer Cell Death
Shijin Zhang, Jiarong Lv, Xing Cheng, et al.
ACS Nano (2025)
Closed Access
In situ enzymatic peptide-based nanomedicine with combined effects for enhanced tumor radio-immunotherapy
Tongxin Gao, Zhilong Wang, Jinhui Zhou, et al.
Chemical Engineering Journal (2024) Vol. 498, pp. 155437-155437
Closed Access | Times Cited: 2
Nanohydroxyapatite-Loaded, Self-Assembled Peptide Gels for Antibacterial and Osteogenic Activities
Pruthviraj Bundel, Vatan Chawla, Ankur Jyoti Saikia, et al.
ACS Applied Nano Materials (2024)
Closed Access | Times Cited: 2
On-Demand Elongation of Peptide Nanofibrils at Cellular Interfaces to Modulate Cell–Cell Interactions
Pan Guo, Xingjing Zhang, Jingsheng Chen, et al.
Nano Letters (2024) Vol. 24, Iss. 36, pp. 11194-11201
Closed Access | Times Cited: 1
Research on enzymatic co-assembly nanomedicine in oral squamous cell carcinoma
Zhijun Xue, Yaxuan Guo, Yuanzhu Zhou, et al.
Precision medicine and engineering. (2024) Vol. 1, Iss. 2, pp. 100008-100008
Open Access | Times Cited: 1
TRPV1-targeted ion-responsive hydrogel against pyroptosis of dry eye disease
Xiangyu Ding, Jingqing Mu, Baoyue Mi, et al.
Chemical Engineering Journal (2024), pp. 156155-156155
Closed Access | Times Cited: 1
Intrinsic PD‐L1 Degradation Induced by a Novel Self‐Assembling Hexapeptide for Enhanced Cancer Immunotherapy
Hongxia Zhang, Ming Ji, Yamei Wang, et al.
Advanced Science (2024) Vol. 12, Iss. 2
Open Access | Times Cited: 1
Synergistic in vivo anticancer effects of 1,7-heptanediol and doxorubicin co-loadedliposomes in highly aggressive breast cancer
Muge Gu, Wei Yu, Sílvio Terra Stefanello, et al.
Journal of Controlled Release (2024) Vol. 377, pp. 174-185
Open Access | Times Cited: 1
Design of Cell-Specific Targeting Peptides for Cancer Therapy
Xiaoyong Chen, Di Wang, Yun‐Bao Jiang, et al.
Targets (2024) Vol. 2, Iss. 3, pp. 186-201
Open Access | Times Cited: 1
Alkaline Phosphatase-Instructed Peptide Assemblies for Imaging and Therapeutic Applications
Chengfan Wu, Pingge Jiang, Wen Su, et al.
Biomacromolecules (2024) Vol. 25, Iss. 9, pp. 5609-5629
Closed Access
Page 1

Scroll to top